Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-09

Clinical Trial Update: Dexmedetomidine Transdermal System (DMTS) for Post-Operative Analgesia Following Bunionectomy [Phase 2]

View source ↗

Summary

Phase 2 trial of a Dexmedetomidine Transdermal System (DMTS) for postoperative analgesia following bunionectomy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine Transdermal System (DMTS) (dexmedetomidine)

Snippet

Sponsor: Teikoku Pharma USA, Inc. | Conditions: Pain, Postoperative | Phase 2 | Status: COMPLETED